What i2a does

i2a (legal name: Intelligence Artificielle Applications) is a Montpellier, France-based specialist in clinical microbiology diagnostics founded in 1986 and incorporated in 1988. The company designs and manufactures automated instruments, middleware software, and consumables for medical bacteriology laboratories, with a primary focus on the automated reading and interpretation of agar-based antibiograms using the Kirby Bauer method. i2a claims to be the first company in the world to develop a fully automated system combining incubation and reading of antibiograms (the SIRscan Orion), alongside a semi-automatic reader (SIRscan Lynx), automated urine sediment analyzers (Urilyzer, UriSed 3 Pro, UriSed Mini), and a slide stainer (RAL Stainer). Its proprietary SIRxpert middleware platform integrates nearly all bacteriology instruments on the market and supports modules for MALDI-TOF identification, epidemiological surveillance, hospital information system connectivity, bidirectional LIS connectivity, and an AI-powered antibiogram reader (Module STAR, launched January 2025) using deep learning for automated zone measurement and disc symbol recognition.

The company generates revenue through a classic medical-device razor-and-blade model: one-time instrument sales (with a 12-month parts and labor warranty), recurring software licenses and middleware subscriptions (multi-user licenses support up to 25 simultaneous users), and a broad recurring consumables catalog that includes antibiotic discs (Sirscan Discs), culture media (MHR-SIR rapid agar), inoculum preparation devices (Inoclic, SIRscan Tubes), MIC strips (Bandelettes CMI), transport swabs (AMIES, Cary Blair, ViCUM, Stuart), staining kits, single-use cuvettes, and Cryoinstant strain preservation systems. Qualiopi-certified training services since 2002 add a professional services revenue layer. Go-to-market is enterprise field sales targeting hospitals and medical biology laboratories in France, augmented by an international distributor network; pricing is quote-based and not publicly disclosed, with free shipping thresholds and 45-day payment terms for private buyers under French public procurement rules.

i2a's customer base includes more than 500 public and private laboratories equipped across France and internationally, and the company is the documented market leader on the French hospital market for antibiogram readers. In 2021, i2a received a strategic investment from Apposite Capital, a healthcare-focused investor, which funded geographic expansion, R&D investment, and recruitment of approximately 30 additional employees. The company operates as a privately held entity with no public listing, subsidiaries, or disclosed M&A activity, and is led by President Jean-Philippe Duvergé and CEO Michel Emelianoff alongside a functional management team covering R&D, software engineering, sales, finance, and operations.

Name

i2a

Legal name

Intelligence Artificielle Applications

Website

https://i2a-diagnostics.fr

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

101–250 employees

Short description

i2a (Intelligence Artificielle Applications) is a Montpellier-based French medical microbiology diagnostics company that designs automated antibiogram readers, urine sediment analyzers, SIRxpert middleware software, and a full range of bacteriology consumables for hospital and clinical laboratories worldwide.

Ownership category

akta.pro rank

Product category

Clinical Microbiology Diagnostic Instruments

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)

akta.pro secondary industries

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Microbiology diagnostics
• Antibiogram instruments
• Clinical laboratory software
• Urine sediment analysis
• Microbiology consumables

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Hardware Instruments: Sale of automated instruments including SIRscan Orion (automated antibiogram incubator-reader), SIRscan Lynx (semi-automatic antibiogram reader), UriSed 3 Pro and UriSed Mini (urine sediment analyzers), RAL Stainer (slide staining automation), and related consumables. Instruments carry a 12-month parts and labor warranty.
2. Software Licenses and Middleware: SIRxpert middleware software platform for clinical microbiology data management. Multi-user licenses allow up to 25 simultaneous users. Software is delivered under a non-exclusive usage license — programs cannot be reproduced, modified, or transferred without i2a's express consent.
3. Reagents and Consumables: Recurring consumables including antibiotic discs (SIRscan Discs), culture media (MHR-SIR rapid antibiogram agar), inoculation devices (Inoclic, SIRscan Tubes, swabs), bandelettes CMI (MIC strips), staining kits (RAL Stainer kits), urine cytology consumables (single-use cuvettes, universal tubes, quality controls), collection and transport swabs (AMIES, Cary Blair, Stuart, ViCUM), and Cryoinstant strain preservation systems.
4. Training Services: Accredited training organization since 2002 offering advanced training sessions to customers. Qualiopi-certified training programs to ensure optimal use of i2a solutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

i2a designs, manufactures, and sells automated microbiological diagnostic instruments (SIRscan Orion/Lynx antibiogram readers, UriSed/Urilyzer urine sediment analyzers, RAL Stainer slide stainers), the SIR Expert/SIRxpert middleware software platform for clinical microbiology data management, and a comprehensive range of reagents and consumables (antibiotic discs, culture media, swabs, staining kits). The company is recognized as the first in the world to develop a fully automated system for incubating, reading, and interpreting agar-based antibiograms.

Product overview

i2a (Intelligence Artificielle Applications) is a specialist in microbiological diagnostic and analysis, recognized as the first company worldwide to design a completely automated system for reading and interpreting agar-based antibiograms. The company offers a comprehensive portfolio organized as automated instruments paired with middleware software and consumables. The instrument portfolio includes SIRscan Orion (fully automated incubator-reader for agar-based antibiograms), SIRscan Lynx (semi-automatic antibiogram reader), Urilyzer and UriSed 3 Pro/Mini (automatic/semi-automatic urine sediment analyzers), and RAL Stainer (slide stainer by immersion). The software ecosystem centers on SIR Expert/SIRxpert middleware platform with specialized modules: SIRxpert Master (expert system for interpretive antibiogram reading), SIRxpert Bacteriology, SIRxpert Antibiogram, SIRxpert MALDI-TOF, SIRxpert Epidemiology, SIRxpert Alert, SIRxpert SIH, SIRxpert bidi, Interface module, Multi-user license, Module STAR (AI-powered antibiogram reading), and SIRxpert Statflash. The company provides a complete range of microbiology reagents and consumables including antibiotic discs (Sirscan Discs), culture media (MHR-SIR), inoculum preparation products (Inoclic, SIRscan Tubes, EUCAST/CLSI Kit), MIC test strips (Bandelettes CMI), collection and transport swabs (AMIES, Cary Blair, ViCUM, Virus, Stuart, dry swabs), stain kits (Gram-Nicolle, Cold ZN, 555, Fluo RAL, Gram-Hucker), quality control materials, strain preservation solutions (Cryoinstant), and laboratory accessories. All products comply with EUCAST, CLSI, and CASFM international standards.

Differentiator

Problem solved

Functional benefit

Products and services

• SIRscan Orion Fully automated incubator-reader for agar-based antibiograms (Kirby Bauer Method). Performs incubation and reading automatically with electronically regulated temperature, high-resolution color camera reading at 60 boxes/hour, continuous loading (4 racks of 11 plates), and MHR results in 6-8 hours. Designed for hospital and clinical microbiology laboratories.
• SIRscan Lynx Semi-automatic reader of antibiograms in agar media using the Kirby Bauer Method. Features HD color camera, automatic symbol detection, continuous reading, and universal expert system for ID/AST result validation. Designed for clinical microbiology laboratories.
• Urilyzer Automatic urine sediment analyzer with no reagent requirement. Uses image capture technology combining conventional and phase-contrast microscopy, detecting all particles including crystals with sub-classification. Throughput of 150 tubes/hour with full traceability and automatic barcode reading.
• UriSed 3 Pro Automatic urine sediment analyzer requiring no reagents or calibrants. Features dual optical systems (classical and phase-contrast microscopy) with image capture technology. Detects all particles including crystals with sub-classification. Capacity of 100 tubes with 600 single-use cuvettes autonomy.
• UriSed Mini Semi-automatic urine sediment analyzer using image capture technology. Manual steps include barcode scanning, mixing/aspiration, and sample injection into cuvette. Throughput of 40 samples/hour with 50 single-use cuvettes autonomy.
• RAL Stainer Slide stainer by immersion for microbiology laboratories. Performs homogeneous and reproducible slide staining, compatible with Gram, Ziehl (cold), Auramine, and MGG staining. Features 20-slide simultaneous loading, closed chamber with charcoal filter, and RFID tracking for dye expiration.
• SIR Expert (SIRxpert) IT platform (middleware) for managing all data and results from clinical microbiology laboratories. Centralizes results from manual work and all bacteriology devices into a single database, with bidirectional connectivity to laboratory management systems and customizable workflow optimization.
• Sirscan Discs High-quality antibiotic discs for antibiogram testing compliant with EUCAST and CLSI recommendations. Available in 1x50 or 5x50 packaging with individually wrapped cartridges. Optimized for use with SIRscan readers for automatic symbol reading.
• MHR-SIR Mueller Hinton Rapid culture medium for fast antibiogram results in agar medium using the Kirby Bauer Method. Provides results in 6-8 hours for most fast-growing bacteria. Automatically read by SIRscan 2000 and SIRscan Orion.
• Inoclic Single-use device for standardized inoculation of bacteria for reproducible and standardized antibiograms. Used for inoculation on agar culture media, tube storage media, or bacterial suspension in liquid media.
• Bandelettes CMI Minimum Inhibitory Concentration (MIC) test strips for precise and rapid antibiogram testing. Determine the lowest antibiotic concentration needed to inhibit bacterial growth, essential for adapting antibiotic treatment.
• Single-Use Cuvettes Single-use cuvettes for UriSed analyzer range. Captive consumable of UriSed instruments with optimal filling design avoiding air bubble formation. Sold in packs of 600 (12x50).
• AMIES Swab Swab for collection and transport of microbiological samples. Maintains viability of aerobic, facultative anaerobic, and strict anaerobic bacteria for minimum 48 hours per CLSI standards.
• Cryoinstant Long-term strain preservation solution with compact cryotubes containing 25 glass cryobeads in cryoprotective medium. Resists temperatures down to -190°C with reliable conservation for several years. Available in 5 colors for color-coded organization.
• Quality Control Materials Quality control materials for UriSed analyzers manufactured from human urine with stabilized RBCs, leukocytes, uric acid, crystals, and preservatives. Ready-to-use liquid form with 2 control levels (high and low).
• Qualiopi-Certified Training Services Accredited professional training services since 2002, Qualiopi-certified, providing advanced training sessions to medical biology laboratory customers on the optimal use of i2a solutions.

Quantifiable outcome

• Over 80% of agar antibiogram plates interpreted without manual correction using STAR AI module
• +5 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability8 records

Feature6 records

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• BD (Becton Dickinson): Major IVD and life sciences company with microbiology offerings including BD MAX, BD Phoenix M50 for AST, and sample collection products. Competes with i2a in hospital microbiology labs but as part of a much broader diagnostic portfolio.
• Beckman Coulter (Danaher): Provides clinical microbiology automation (e.g., DxM MicroScan WalkAway for AST) and laboratory information systems. Overlaps with i2a in antibiogram and lab workflow management, with much larger global reach.
• bioMérieux: Global leader in clinical microbiology, offering bacterial identification, AST, and lab automation solutions. Directly overlaps with i2a's ID/AST franchise, but operates at vastly greater scale with broader portfolio including VITEK, BACT/ALERT, and BIOBALL.
• bio-Rad Laboratories: Diversified life science and clinical diagnostics company with microbiology products including QC organisms and AST systems. Overlaps with i2a in clinical microbiology while serving much broader life science markets.

Emerging players

• Q-linea: Swedish developer of rapid AST systems (ASTar) for bloodstream infections. Competes in the broader rapid AST segment that could overlap with i2a's faster antibiogram positioning (MHR-SIR 6-8 hour results).
• COPAN Diagnostics: Specialist in pre-analytical microbiology, particularly automated sample collection and transport systems (e.g., WASP, eSwab). Adjacent to i2a's transport swab business (AMIES, Cary Blair) and microbiology automation strategy.
• Accelerate Diagnostics: Focused on rapid phenotypic antibiotic susceptibility testing with the Accelerate Pheno system. Competes with i2a on speed of AST results but takes a different technology approach (fluidics-based rapid AST rather than automated agar reading).

Direct peers

• Mast Group: UK-based specialist in clinical microbiology diagnostics, offering antibiotic discs, AST systems, culture media, and identification products. Closely mirrors i2a's product portfolio and target customer base (clinical microbiology labs).
• Liofilchem: Italian manufacturer of clinical microbiology products including antibiotic discs, MIC strips, culture media, and identification systems. Closely comparable in size and product scope to i2a's reagent and consumable business, competing head-to-head in European labs.
• Hardy Diagnostics: US manufacturer of microbiology culture media, reagents, and diagnostic instruments serving clinical and industrial labs. Comparable to i2a in the consumables and reagents segment of clinical microbiology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/i2a_diagnostics
• YouTubeyoutube.com/@i2aintelligenceartificiell612
• LinkedInlinkedin.com/company/i2a
• Facebookfacebook.com/I2A-info-343889516405485

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about i2a